Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |